Savi Overseas

Tirzepatide mimics and enhances the activity of two naturally occurring hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which regulate blood sugar, appetite, and energy balance. It increases insulin secretion in response to high blood sugar while reducing glucagon, a hormone that raises blood sugar levels, leading to improved glucose control.

Additionally, Tirzepatide slows the rate at which food leaves the stomach, prolonging the feeling of fullness and reducing the urge to eat more. It also acts on brain receptors to suppress appetite and promote satiety. This dual-receptor action makes Tirzepatide more effective in lowering blood sugar and supporting weight loss than single-hormone therapies.